These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1087 related articles for article (PubMed ID: 23606701)

  • 1. Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?
    Millet A; Pederzoli-Ribeil M; Guillevin L; Witko-Sarsat V; Mouthon L
    Ann Rheum Dis; 2013 Aug; 72(8):1273-9. PubMed ID: 23606701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Republished: Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?
    Millet A; Pederzoli-Ribeil M; Guillevin L; Witko-Sarsat V; Mouthon L
    Postgrad Med J; 2014 May; 90(1063):290-6. PubMed ID: 24737903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of ANCA-associated vasculitis: new possibilities for intervention.
    Kallenberg CG; Stegeman CA; Abdulahad WH; Heeringa P
    Am J Kidney Dis; 2013 Dec; 62(6):1176-87. PubMed ID: 23810690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of PR3-ANCA associated vasculitis.
    Kallenberg CG
    J Autoimmun; 2008; 30(1-2):29-36. PubMed ID: 18162369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides.
    Bonaci-Nikolic B; Nikolic MM; Andrejevic S; Zoric S; Bukilica M
    Arthritis Res Ther; 2005; 7(5):R1072-81. PubMed ID: 16207324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis.
    Mahr A; Katsahian S; Varet H; Guillevin L; Hagen EC; Höglund P; Merkel PA; Pagnoux C; Rasmussen N; Westman K; Jayne DR;
    Ann Rheum Dis; 2013 Jun; 72(6):1003-10. PubMed ID: 22962314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides.
    Kallenberg CG; Heeringa P; Stegeman CA
    Nat Clin Pract Rheumatol; 2006 Dec; 2(12):661-70. PubMed ID: 17133251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies.
    Choi HK; Liu S; Merkel PA; Colditz GA; Niles JL
    J Rheumatol; 2001 Jul; 28(7):1584-90. PubMed ID: 11469466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-neutrophil cytoplasmic antibody(ANCA), MPO-ANCA, PR3-ANCA].
    Takizawa H
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():694-6. PubMed ID: 20942166
    [No Abstract]   [Full Text] [Related]  

  • 10. Pathogenesis of ANCA-associated vasculitides.
    Kallenberg CG
    Ann Rheum Dis; 2011 Mar; 70 Suppl 1():i59-63. PubMed ID: 21339221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Review article: Antineutrophil cytoplasmic antibody in small vessel vasculitis].
    Nakano H; Ozaki S
    Rinsho Byori; 2010 May; 58(5):480-9. PubMed ID: 20560457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current landscape of antineutrophil cytoplasmic antibody-associated vasculitis: classification, diagnosis, and treatment.
    Lally L; Spiera R
    Rheum Dis Clin North Am; 2015; 41(1):1-19, vii. PubMed ID: 25399936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients.
    Harper L; Radford D; Plant T; Drayson M; Adu D; Savage CO
    Arthritis Rheum; 2001 Apr; 44(4):921-30. PubMed ID: 11315931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New advances in the pathogenesis of ANCA-associated vasculitides.
    Chen M; Kallenberg CG
    Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S108-14. PubMed ID: 19646356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The complexity of classifying ANCA-associated small-vessel vasculitis in actual clinical practice: data from a multicenter retrospective survey.
    Corral-Gudino L; González-Vázquez E; Calero-Paniagua I; Pérez-Garrido L; Cusacovich I; Rivas-Lamazares A; Quesada-Moreno A; González-Fernández A; Mora-Peña D; Lerma-Márquez JL; Del-Pino-Montes J
    Rheumatol Int; 2020 Feb; 40(2):303-311. PubMed ID: 31385079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient Subsets.
    Miloslavsky EM; Lu N; Unizony S; Choi HK; Merkel PA; Seo P; Spiera R; Langford CA; Hoffman GS; Kallenberg CG; St Clair EW; Tchao NK; Fervenza F; Monach PA; Specks U; Stone JH
    Arthritis Rheumatol; 2016 Dec; 68(12):2945-2952. PubMed ID: 27428559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. -463 G/A myeloperoxidase promoter polymorphism is associated with clinical manifestations and the course of disease in MPO-ANCA-associated vasculitis.
    Reynolds WF; Stegeman CA; Tervaert JW
    Clin Immunol; 2002 May; 103(2):154-60. PubMed ID: 12027420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive Granulomatosis With Polyangiitis (Wegener's) Is a Clinically Distinct Subset of ANCA-Associated Vasculitis: A Retrospective Analysis of 315 Patients From a German Vasculitis Referral Center.
    Schirmer JH; Wright MN; Herrmann K; Laudien M; Nölle B; Reinhold-Keller E; Bremer JP; Moosig F; Holle JU
    Arthritis Rheumatol; 2016 Dec; 68(12):2953-2963. PubMed ID: 27333332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and management of pulmonary vasculitis.
    Yunt ZX; Frankel SK; Brown KK
    Ther Adv Respir Dis; 2012 Dec; 6(6):375-90. PubMed ID: 22878624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and prognostic features of Korean patients with MPO-ANCA, PR3-ANCA and ANCA-negative vasculitis.
    Yoo J; Kim HJ; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Clin Exp Rheumatol; 2017; 35 Suppl 103(1):111-118. PubMed ID: 28339364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.